$15.85+0.48 (+3.12%)
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
Perrigo Company plc in the Healthcare sector is trading at $15.85 with a market capitalization of $1.9B. Wall Street consensus targets $16.50 (4 analysts), implying a +4.1% move over the next 12 months. The stock is currently 28% below its 52-week high of $22.02, remaining 33.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.02Bβ | $969.20Mβ | $1.11Bβ | $1.04Bβ | $1.06B |
| Gross Profit | $313.90Mβ | $325.50Mβ | $362.20Mβ | $377.10Mβ | $362.90M |
| Operating Income | $39.00Mβ | $33.60Mβ | $84.40Mβ | $93.40Mβ | $55.60M |
| Net Income | $74.50Mβ | -$398.60Mβ | -$1.42Bβ | $7.50Mβ | -$8.40M |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper res...